Loading...
NPI 1245263292 · Hixson, TN · Ambulatory Surgical Clinic/Center
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Chattanooga Pain Management Center LLC is a ambulatory surgical clinic/center provider located in Hixson, Tennessee. This profile covers 14 Medicare and 3 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Chattanooga Pain Management Center LLC |
| Address | 1016 Executive Dr |
| City | Hixson |
| State | TN |
| ZIP | 37343 |
| Taxonomy | Ambulatory Surgical Clinic/Center |
| NPI Enumerated | July 9, 2006 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $2.4M |
| Medicaid | $1.6K |
CHATTANOOGA PAIN MANAGEMENT CENTER LLC is classified as an Ambulatory Surgical Clinic/Center and its Medicare billing mix is dominated by advanced interventional spine procedures and neuromodulation. The three highest‑revenue Medicare codes — 63685, 63650, and 64635 — together account for 68.3% of the provider's total Medicare revenue, indicating a focused service line centered on spinal neurostimulator implantation, epidural electrode placement, and neurolytic ablation techniques.
The provider's overall payer mix is effectively Medicare‑dominated: lifetime Medicare revenue is $2.4M compared with just $1.6K in Medicaid revenue. Medicaid activity is negligible relative to Medicare and concentrated entirely in a single Medicaid billable code, so the practice operates functionally as a near single‑payer (Medicare) specialty center.
Code‑level competitive standing is mixed but skewed toward high intensity for certain interventional services. 64635 is a notable national outlier — ranked #3 of 5957 providers and labeled an "extreme outlier" — signaling far above‑typical national volume for lower back neurolytic procedures, while 63650 ranks #60 of 1371 (96th percentile; "notably above typical") and 63685 ranks #81 of 1281 (94th percentile; reported as "typical, unremarkable" volume).
Beyond the top three, the practice reports very high volumes of image‑guided facet and epidural injections and related ablation codes: 64493, 64633, and 64490 each appear at the 100th percentile and are described as "extreme outlier" volumes nationally. This pattern — heavy, concentrated use of facet injections, transforaminal epidurals (64483), and radiofrequency/neurolytic procedures — is consistent with a high‑throughput interventional pain clinic performing both diagnostic/therapeutic injections and ablative interventions.
Medicaid billing is minimal and narrowly concentrated: the Medicaid portfolio shows 64483 accounting for 100.0% of the provider's Medicaid revenue ($1.6K) and ranks #36 of 39 in‑state (5th percentile; "typical, unremarkable" volume). The disparity between Medicare and Medicaid scale suggests limited Medicaid participation or credentialing and implies Medicare claims will dominate utilization and contracting analyses.
The provider's tenure in the national enrollment system is long; the NPI was enumerated 2006-07-09 (~20 years ago). Combined with $2.4M lifetime Medicare revenue, this longevity supports an established local presence and an entrenched procedural practice model rather than a recently launched operation.
High revenue concentration in a handful of interventional codes (top three = 68.3% of Medicare revenue) plus multiple codes flagged as "extreme outlier" warrants attention from payers and analysts focused on utilization management, network adequacy, and peer benchmarking. These patterns are consistent with a specialized, high‑volume interventional spine practice and should be evaluated alongside referral sources, case complexity, and facility capacity when considering contracting or audit workflows.
Operationally, the mix of procedures — spinal neurostimulator implantation (63685), epidural electrode placement (63650), and frequent neurolytic/ablative procedures (64635 and others) — implies the center maintains in‑suite imaging and surgical capability typical of ambulatory surgical centers. Analysts should anticipate procedural throughput, device supply costs, and post‑procedure follow‑up resource needs when modeling the provider's cost and revenue profile.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
14 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 63685 | The provider inserts or replaces a spinal neurostimulator pulse generator or receiver. The system is one that requires surgical creation of a pocket for placement and that requires a connection… | 50 | $16,780 | $755K |
| 63650 | In this procedure, the provider places electrodes in the epidural space to relieve pain and reduce or eliminate spasms. | 160 | $3,510 | $547.2K |
| 64635 | Under fluoroscopic or CT guidance, the provider applies an agent to a lower back joint to destroy nerve tissue. | 670 | $470 | $309.2K |
| 64493 | The provider injects a diagnostic or therapeutic substance into a single lumbar or sacral paravertebral facet (zygapophyseal) joint, or into the nerves that supply that joint, using imaging guidance… | 590 | $230 | $137.9K |
| 64483 | This procedure is the injection of an anesthetic agent and/or steroid in the form of a transforaminal epidural injection into a single level (either lumbar or sacral). | 480 | $260 | $125.5K |
| 0275T | N/A | 40 | $3,470 | $121.3K |
| 64633 | In this procedure, the provider destroys the facet joint nerve of a cervical or thoracic spinal segment using neurolytic agents like heat, electric current, or a chemical compound. He makes use of… | 210 | $490 | $102.1K |
| 64490 | The provider injects a diagnostic or therapeutic substance into a single cervical or thoracic paravertebral facet (zygapophyseal) joint, or into the nerves that supply that joint, using imaging… | 310 | $240 | $74.2K |
| 0627T | The provider injects a cellular or tissue–based product under fluoroscopic guidance to treat a lumbar intervertebral disc. This code applies to the first level injected. The injection may occur on… | 10 | $6,710 | $73.9K |
| G0260 | Injection procedure for sacroiliac joint; provision of anesthetic, steroid and/or other therapeutic agent, with or without arthrography | 220 | $170 | $36.9K |
Showing 1–10 of 14
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 14 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
14 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| 63685 | 3 | 40 | 20 | $6,810 | $170.2K |
| 63650 | 4 | 40 | 50 | $1,650 | $123.8K |
| 0275T | 3 | 10 | 20 | $1,940 | $77.5K |
| 0627T | 1 | 10 | 10 | $6,710 | $73.8K |
| 64483 | 8 | 150 | 70 | $190 | $25.8K |
| 64635 | 1 | 150 | 40 | $360 | $25.6K |
| G0260 | 4 | 20 | 60 | $190 | $20K |
| 64493 | 3 | 160 | 60 | $180 | $16.9K |
| 62323 | 31 | 150 | 50 | $150 | $14.8K |
| 64633 | 1 | 60 | 30 | $350 | $13.1K |
Showing 1–10 of 14
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
3 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 64483 | This procedure is the injection of an anesthetic agent and/or steroid in the form of a transforaminal epidural injection into a single level (either lumbar or sacral). | 20 | $80 | $1.6K |
| G8907 | Patient documented not to have experienced any of the following events: a burn prior to discharge; a fall within the facility; wrong site/side/patient/procedure/implant event; or a hospital transfer… | 310 | $0 | $0 |
| G8918 | Patient without preoperative order for iv antibiotic surgical site infection (ssi) prophylaxis | 290 | $0 | $0 |
How this provider's Medicaid billing volume and revenue compare to other Tennessee providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Tennessee median
3 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 64483 | This procedure is the injection of an anesthetic agent and/or steroid in the form of a transforaminal epidural injection into a single level (either lumbar or sacral). | 36 | 40 | 210 | $90 | $49.7K |
| G8907 | Patient documented not to have experienced any of the following events: a burn prior to discharge; a fall within the facility; wrong site/side/patient/procedure/implant event; or a hospital transfer… | 23 | 70 | 160 | $1 | $10 |
| G8918 | Patient without preoperative order for iv antibiotic surgical site infection (ssi) prophylaxis | 15 | 50 | 100 | $0 | $0 |
Other providers in the same ZIP code as Chattanooga Pain Management Center LLC, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Galen Medical Group, PC | TN | Internal Medicine Physician | $0 | $10.2M |
| Agilitas Usa Inc | TN | Physical Therapy Clinic/Center | $0 | $7.4M |
| Dental Center, Inc | TN | Dentist | $0 | $7.4M |
| Lighthouse Kids Hixson, LLC | TN | Behavior Analyst | $0 | $3.7M |
| Devon Ghodasra | TN | Retina Specialist (Ophthalmology) Physician | $3.6M | $0 |
| Hixson Pediatric Dentistry PLLC | TN | Pediatric Dentistry | $0 | $3.2M |
| Rohan Shah | TN | Retina Specialist (Ophthalmology) Physician | $2.9M | $0 |
| Memorial Health Care System Inc. | TN | General Acute Care Hospital | $0 | $2.4M |
| Francis Decroos | TN | Retina Specialist (Ophthalmology) Physician | $2.3M | $0 |
| Chelsea Schwind | TN | Dentist | $0 | $2.2M |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.